We are live on ! Find out more
Swiss National Bank

Swiss National Bank Portfolio holdings

AUM $174B
1-Year Est. Return 30.96%
 

The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.

This Fund
S&P 500
This Quarter Est. Return
+4%
1 Year Est. Return
+30.96%
3 Year Est. Return
+104.8%
5 Year Est. Return
+143.7%
10 Year Est. Return
+536.36%
AUM
$61.8B
AUM Growth
+$7.3B
Cap. Flow
+$3.47B
Cap. Flow %
5.61%
Top 10 Hldgs %
15.31%
Holding
2,670
New
59
Increased
1,417
Reduced
325
Closed
89

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$106M
2
NXPI icon
NXP Semiconductors
NXPI
+$93.6M
3
BABA icon
Alibaba
BABA
+$90M
4
XOM icon
ExxonMobil
XOM
+$83.7M
5
CHTR icon
Charter Communications
CHTR
+$82.8M

Sector Composition

Rank Sector Weight
1 Healthcare 15.13%
2 Technology 14.52%
3 Consumer Staples 10.68%
4 Consumer Discretionary 10.21%
5 Industrials 9.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NDLS icon
2551
Noodles & Co
NDLS
$96M
$226K ﹤0.01%
2,888
-437
-13% -$36.3K
DGICA icon
2552
Donegal Group Class A
DGICA
$693M
$223K ﹤0.01%
13,500
KRO icon
2553
KRONOS Worldwide
KRO
$977M
$221K ﹤0.01%
42,000
ESPR
2554
DELISTED
Esperion Therapeutics
ESPR
$219K ﹤0.01%
22,200
+1,500
+7% +$24.9K
ZVO
2555
DELISTED
Zovio Inc. Common Stock
ZVO
$217K ﹤0.01%
30,000
COLL icon
2556
Collegium Pharmaceutical
COLL
$882M
$212K ﹤0.01%
+17,900
New +$296K
BOJA
2557
DELISTED
Bojangles', Inc. Common Stock
BOJA
$208K ﹤0.01%
12,300
BATRA icon
2558
Atlanta Braves Holdings Series A
BATRA
$3.42B
$194K ﹤0.01%
+12,922
New +$199K
ULH icon
2559
Universal Logistics Holdings
ULH
$498M
$183K ﹤0.01%
14,170
USLM icon
2560
United States Lime & Minerals
USLM
$3.45B
$183K ﹤0.01%
15,500
AC
2561
DELISTED
Associated Capital Group
AC
$178K ﹤0.01%
6,231
NRC icon
2562
NRC Health Common Stock
NRC
$462M
$177K ﹤0.01%
+12,900
New +$182K
OMED
2563
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$175K ﹤0.01%
14,200
RGLS
2564
DELISTED
Regulus Therapeutics
RGLS
$168K ﹤0.01%
485
+41
+9% +$29.4K
ENTL
2565
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
$163K ﹤0.01%
8,900
TCS
2566
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
$162K ﹤0.01%
2,023
AGFS
2567
DELISTED
AgroFresh Solutions Inc
AGFS
$162K ﹤0.01%
30,500
GRBK icon
2568
Green Brick Partners
GRBK
$3.03B
$145K ﹤0.01%
19,900
KRNT icon
2569
Kornit Digital
KRNT
$778M
$140K ﹤0.01%
14,300
+6,000
+72% +$58.9K
PMTS icon
2570
CPI Card Group
PMTS
$330M
$137K ﹤0.01%
+5,460
New +$168K
MOBL
2571
DELISTED
MobileIron, Inc.
MOBL
$130K ﹤0.01%
42,500
PZN
2572
DELISTED
Pzena Investment Management, Inc. Class A
PZN
$129K ﹤0.01%
16,900
MRTX
2573
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$115K ﹤0.01%
21,000
INFI
2574
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$104K ﹤0.01%
77,900
-5,100
-6% -$23.9K
IMDZ
2575
DELISTED
Immune Design Corp.
IMDZ
$102K ﹤0.01%
12,500
+1,600
+15% +$20K

Similar funds

Swiss National Bank's Q2 2016 Portfolio in Review

As of Q2 2016, Swiss National Bank held 2,670 positions worth $61.8B, up 13% from $54.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Swiss National Bank deployed $3.47B of net new capital in Q2 2016, opening 59 new positions and adding to 1,417 existing holdings. Its largest new stake was Under Armour Class C: 522,612 shares worth $19M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Technology and Consumer Staples.

On the sell side, the largest reduction was Kimberly-Clark, an estimated $19.6M trimmed.

  • Swiss National Bank's largest Q2 2016 buy was Under Armour Class C: 522,612 shares worth $19M.
  • Swiss National Bank added most to Apple in Q2 2016, an estimated $106M increase.
  • Swiss National Bank's biggest Q2 2016 reduction was Kimberly-Clark, cutting an estimated $19.6M.
  • Swiss National Bank fully exited Brookfield in Q2 2016, selling an estimated $162M.
  • Swiss National Bank's ten largest holdings make up 15% of its $61.8B portfolio in Q2 2016.
  • Swiss National Bank opened 59 new positions and closed 89 in Q2 2016.
  • Swiss National Bank's portfolio value rose 13% quarter-over-quarter to $61.8B.

Based on Swiss National Bank's 13F filing for Q2 2016, filed 3 Aug 2016.